The Latest Furor Over Trump’s Drug Pricing Plan
Executive Summary
Did the head of the Office and Management & Budget really endorse Part D rebates? Like so much about the Trump Administration’s response to drug pricing, there is probably a lot less to the story than it sounds.
You may also be interested in...
The US Drug Pricing Hearing Pharma Wants
Senate hearing will examine drug delivery system, but industry still faces possibility of another public shaming about increasing drug costs.
The US Drug Pricing Hearing Pharma Wants
Senate hearing will examine drug delivery system, but industry still faces possibility of another public shaming about increasing drug costs.
HHS Action On Drug Pricing: Here's Who Secretary Price Is Listening To
HHS is expected to move ahead with action to address high drug prices following a series of stakeholder roundtables held over the past month.